Medical Condition News

RSS

FDA takes action to remove illegal diabetes products from market

The U.S. Food and Drug Administration is taking action to remove from the market illegal products, including some labeled as dietary supplements, that claim to mitigate, treat, cure or prevent diabetes and related complications.

24 Jul 2013

Astrocytes can protect brain tissue and reduce disability due to stroke

One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.

24 Jul 2013

TYRX's AIGISRx Antibacterial Envelope gets FDA clearance

TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance to market the AIGISRx Antibacterial Envelope for use with vagus nerve stimulators, which are currently used to treat seizure disorders and depression.

24 Jul 2013

Digital versions of standard molecular biology tool to detect common tumor-associated mutation in CSF

Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.

24 Jul 2013

New approaches provide lifetime support for individuals with ASD

More than 300 parents, healthcare providers and educators from across the U.S. and around the world, will come together July 26 through July 27, 2013 at the second annual national conference for families and professionals, "Treating the Whole Person with Autism: Care Across the Lifespan." The conference — sponsored by Autism Speaks, the world's leading autism and advocacy organization, with our educational partners at Nationwide Children's Hospital, Ohio State University Wexner Medical Center, the U.S.

24 Jul 2013

Study: Kidney stones linked with increased risk of CHD among women, but not men

An analysis of data from three studies that involved a total of more than 240,000 participants found that a self-reported history of kidney stones was associated with a statistically significant increased risk of coronary heart disease among women but no significant association was evident for men, according to a study in the July 24/31 issue of JAMA.

24 Jul 2013

Research: No association between pre-natal mercury exposure and autism-like behaviors

The potential impact of exposure to low levels of mercury on the developing brain - specifically by women consuming fish during pregnancy - has long been the source of concern and some have argued that the chemical may be responsible for behavioral disorders such as autism.

24 Jul 2013

Prana Biotechnology completes PBT2 phase 2 trial in patients with Huntington's disease

Prana Biotechnology today announced the successful completion of Reach2HD, a phase 2 clinical trial in patients with early to mid-stage Huntington disease. The Company expects to announce the results arising from the trial in October.

23 Jul 2013

MUCMD Symposium to be held at The Saban Research Institute of Children's Hospital Los Angeles

On August 16 and 17, the 3rd annual Meaningful Use of Complex Medical Data Symposium is returning to The Saban Research Institute of Children's Hospital Los Angeles.

23 Jul 2013

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Presently, it is a diagnosis of exclusion. Patients end up spending, according to what’s been published in the medical literature, as many as 3 - 5 years going from doctor to doctor seeking a diagnosis because they tend to have nonspecific symptoms of a subjective nature.

23 Jul 2013

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

Array BioPharma Inc. today announced positive results from a placebo-controlled, randomized, double‑blind Phase 2 trial in mild to moderate persistent allergic asthma for ARRY-502, an oral CRTh2 antagonist.

23 Jul 2013

Discovery may help explain how anti-inflammatory steroid drugs work

A gene long presumed dead comes to life under the full moon of inflammation, Stanford University School of Medicine scientists have found.

23 Jul 2013

Novaliq receives CE mark approval for EyeSol technology

Novaliq GmbH, a drug delivery company with a focus on the topical application of ophthalmic technologies for poorly soluble drugs, today announced the successful CE mark approval for the first topical eye lubricant based on Novaliq's proprietary technology EyeSol.

23 Jul 2013

Incentives for Ontario surgeons drive greater use of laparoscopic colon cancer surgery

Financial incentives for Ontario surgeons are likely a key factor driving greater use of laparoscopic colon cancer surgery, says a study led by a McMaster University surgeon.

23 Jul 2013

Understanding cancer at source could improve disease prevention

A new disease is affecting developing countries, deadlier than malaria, AIDS and tuberculosis combined. With changes in lifestyles, cancer is spreading in southern countries.

23 Jul 2013

Potential breakthrough to help prevent diabetes

The resistance to insulin seen in type 2 diabetics is caused partly by the lack of a protein that has not previously been associated with diabetes. This breakthrough could potentially help to prevent diabetes.

23 Jul 2013

Research findings on brain development may shed light on neurological disorders

Dennis O'Leary of the Salk Institute was the first scientist to show that the basic functional architecture of the cortex, the largest part of the human brain, was genetically determined during development.

23 Jul 2013

Complications of preventable conditions more likely to land former prisoners in hospital

Complications of diabetes, hypertension, asthma, and other preventable conditions are more likely to land former prisoners in the hospital, Yale School of Medicine researchers report in the July 22 online issue of JAMA Internal Medicine.

23 Jul 2013

Study shows integrative approach reduces pain severity, improves mood and quality of life

An integrative approach to treating chronic pain significantly reduces pain severity while improving mood and quality of life, according to a new study from the Bravewell Practice-Based Research Network (BraveNet) published last month in BioMed Central Complementary and Alternative Medicine journal.

23 Jul 2013

Researchers suggest new key to switch off signaling pathways that lead to hypertension

A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the body to regulate blood pressure. The most promising of them may literally be the key to controlling hypertension, switching off the signaling pathways that lead to the deadly condition.

23 Jul 2013

Medical Condition News

FDA takes action to remove illegal diabetes products from market

Astrocytes can protect brain tissue and reduce disability due to stroke

TYRX's AIGISRx Antibacterial Envelope gets FDA clearance

Digital versions of standard molecular biology tool to detect common tumor-associated mutation in CSF

New approaches provide lifetime support for individuals with ASD

Study: Kidney stones linked with increased risk of CHD among women, but not men

Research: No association between pre-natal mercury exposure and autism-like behaviors

Prana Biotechnology completes PBT2 phase 2 trial in patients with Huntington's disease

MUCMD Symposium to be held at The Saban Research Institute of Children's Hospital Los Angeles

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Array BioPharma announces positive results from ARRY-502 Phase 2 trial for allergic asthma

Discovery may help explain how anti-inflammatory steroid drugs work

Novaliq receives CE mark approval for EyeSol technology

Incentives for Ontario surgeons drive greater use of laparoscopic colon cancer surgery

Understanding cancer at source could improve disease prevention

Potential breakthrough to help prevent diabetes

Research findings on brain development may shed light on neurological disorders

Complications of preventable conditions more likely to land former prisoners in hospital

Study shows integrative approach reduces pain severity, improves mood and quality of life

Researchers suggest new key to switch off signaling pathways that lead to hypertension

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News